Literature DB >> 19241153

Serum neuron specific enolase and malondialdehyde in patients after out-of-hospital cardiac arrest.

Miroslav Sulaj1, Beata Saniova, Eva Drobna, Jela Schudichova.   

Abstract

BACKGROUND: Sudden cardiac arrest (CA) is a leading cause of death in Europe. The victims of CA need immediate cardiopulmonary resuscitation (CPR). Patients resuscitated due to CA have high mortality rate. Prognostic evaluation based on clinical observation is uncertain and would benefit from the use of biochemical markers of hypoxic brain damage. Multiple factors of brain origin can be measured in blood.
OBJECTIVE: The purpose of this study was to validate the use of the serum neuron-specific enolase (NSE) and malondialdehyde (MDA) concentrations for predicting in-hospital death, after resuscitation from out-of-hospital CA. Neuronal damage and impairment of the blood-brain-barrier integrity can be detected by the release of NSE into cerebrospinal fluid and eventually into the blood. MDA represents a product of lipid peroxide decomposition reactions.
METHODS: In a prospective study of 35 consecutive survivors of out-of-hospital CA, serum samples were obtained within 24, 72 and 168 h after the CA. NSE and MDA concentrations were measured, relationship between concentration in group of in-hospital death and survived patients were examined. Results There was a significant difference in NSE concentration between survivors and dead group on 1st day of measurement, marginally significant difference on 3rd day and no statistically significant difference in NSE on 7th day of measurement. There was marginally significant difference in MDA levels in both groups in all days of measurements.
CONCLUSION: Estimation serum concentrations of NSE but not MDA seems to be a predictor of fate of patients after CA. The exact nature of oxidative stress can only be resolved by further studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241153     DOI: 10.1007/s10571-009-9361-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  3 in total

1.  Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.

Authors:  Rachel Pardes Berger; Mary Clyde Pierce; Stephen R Wisniewski; P David Adelson; Robert S B Clark; Randy A Ruppel; Patrick M Kochanek
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

2.  Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.

Authors:  Marjaana Tiainen; Risto O Roine; Ville Pettilä; Olli Takkunen
Journal:  Stroke       Date:  2003-11-20       Impact factor: 7.914

3.  Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100.

Authors:  Neil R Grubb; Catriona Simpson; Roy A Sherwood; Hagosa D Abraha; Stuart M Cobbe; Ronan E O'Carroll; Ian Deary; Keith A A Fox
Journal:  Heart       Date:  2007-05-13       Impact factor: 5.994

  3 in total
  3 in total

Review 1.  Neuroprognostication of hypoxic-ischaemic coma in the therapeutic hypothermia era.

Authors:  David M Greer; Eric S Rosenthal; Ona Wu
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

2.  Hydrogen sulfide improves neural function in rats following cardiopulmonary resuscitation.

Authors:  Ji-Yan Lin; Min-Wei Zhang; Jin-Gao Wang; Hui Li; Hong-Yan Wei; Rong Liu; Gang Dai; Xiao-Xing Liao
Journal:  Exp Ther Med       Date:  2015-12-16       Impact factor: 2.447

3.  Safety and Efficacy of Remote Ischemic Preconditioning in Patients With Severe Carotid Artery Stenosis Before Carotid Artery Stenting: A Proof-of-Concept, Randomized Controlled Trial.

Authors:  Wenbo Zhao; Ran Meng; Chun Ma; Baojun Hou; Liqun Jiao; Fengshui Zhu; Weijuan Wu; Jingfei Shi; Yunxia Duan; Renling Zhang; Jing Zhang; Yongxin Sun; Hongqi Zhang; Feng Ling; Yuping Wang; Wuwei Feng; Yuchuan Ding; Bruce Ovbiagele; Xunming Ji
Journal:  Circulation       Date:  2017-02-07       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.